Skip to Main Content
Back to News

Insider Sale: CHIEF COMMERCIAL OFFICER of $HRMY Sells 1,629 Shares

Automated

Jeffrey Dierks, the CHIEF COMMERCIAL OFFICER of $HRMY, sold 1,629 shares of the company on 01-27-2025 for an estimated $61,941. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $HRMY stock.

$HRMY Insider Trading Activity

$HRMY insiders have traded $HRMY stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $HRMY stock by insiders over the last 6 months:

  • IV PHARMA HOLDINGS, LLC VALOR has made 0 purchases and 2 sales selling 4,600,000 shares for an estimated $139,391,500.
  • FUND TRUST II MARSHMAN has made 0 purchases and 2 sales selling 4,600,000 shares for an estimated $139,391,500.
  • JEFFREY DIERKS (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 11 sales selling 120,981 shares for an estimated $4,683,133.
  • SANDIP KAPADIA (CHIEF FINANCIAL OFFICER) has made 0 purchases and 2 sales selling 26,775 shares for an estimated $1,072,144.
  • JEFFREY M. DAYNO (PRESIDENT, CEO) sold 19,293 shares for an estimated $774,245

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$HRMY Hedge Fund Activity

We have seen 107 institutional investors add shares of $HRMY stock to their portfolio, and 111 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles